Shareholders Equity: The sum of preferred and common equity items.
Revive Therapeutics Ltd. (V.RVV) had Shareholders Equity of 22.46M for the most recently reported fiscal year, ending 2021-06-30.
| Income Statement Financials | |
-- |
|
-15.69M |
|
-- |
|
-- |
|
-- |
|
-14.48M |
|
-- |
|
-15.69M |
|
-15.83M |
|
-15.69M |
|
-15.69M |
|
-15.69M |
|
-15.83M |
|
-14.48M |
|
-14.48M |
|
267.49M |
|
267.49M |
|
-0.06 |
|
-0.06 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
23.24M |
|
-- |
|
-- |
|
-- |
|
0.78M |
|
22.46M |
|
12.71M |
|
|
Shareholders Equity |
22.46M |
317.96M |
|
| Cash Flow Statement Financials | |
-6.48M |
|
-2.12M |
|
20.46M |
|
1.08M |
|
12.94M |
|
11.87M |
|
6.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.11 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-69.84% |
|
-123.38% |
|
-67.50% |
|
-69.06% |
|
0.09 |
|
-0.02 |
|
-0.02 |
|